Genital Warts

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-02-01
Clinical Trial Update: A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) [Phase 3]
A Phase 3 study evaluating Gardasil (qHPV) in mid-adult women to assess safety, immune response, and efficacy; the trial is completed and re…
CLINICAL_TRIALS trial_result · 2009-11-26
Clinical Trial Update: Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) [Phase 3]
Phase 3 clinical trial update for Gardasil evaluating prevention of cervical cancer and genital warts; the study has been completed and resu…
CLINICAL_TRIALS trial_result · 2009-11-25
Clinical Trial Update: Low Dose Cyclophosphamide Treats Genital Warts [Phase 3]
Phase 3 trial evaluating low-dose cyclophosphamide for genital warts has completed. The update does not provide efficacy results in the snip…
CLINICAL_TRIALS trial_result · 2009-11-20
Clinical Trial Update: Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) [Phase 3]
Phase 3 trial evaluating Gardasil's efficacy against cervical intraepithelial neoplasia lesions and genital warts in women; completed with r…
CLINICAL_TRIALS trial_result · 2009-07-13
Clinical Trial Update: Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) [Phase 3]
Phase 3 trial evaluating the safety of administering Gardasil concurrently with a combined Diphtheria/Tetanus/Pertussis vaccine and a Mening…
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2009-04-09
Clinical Trial Update: Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts [Phase 1]
This update reports on a Phase 1 safety and preliminary effectiveness study of GS-9191, an experimental topical ointment, for the treatment …